Design of the study: How can health care help female breast cancer patients reduce their stress symptoms? A randomized intervention study with stepped-care

BMC Cancer

Karin Nordin⁴  Ritva Rissanen³  Johan Ahlgren¹  Gunilla Burell³  Marie-Louise Fjällskog⁵  Susanne Börjesson²  Cecilia Arving³ 

[1] Department of Oncology, Gävle hospital, and Centre for Research and Development, Uppsala University, Uppsala, Sweden

[2] Department of Surgery, Central Hospital of Falun, Falun, Sweden

[3] Department of Public Health and Caring Sciences, Uppsala University, Box 564, Uppsala, SE-751 22, Sweden

[4] Department of Public Health and Primary Health Care, University of Bergen, Bergen, Norway

[5] Department of Oncology, Radiology and Clinical Immunology, Uppsala University, Uppsala, Sweden

关键词: Stress management;    Randomized multicenter interventions study with stepped-care approach;    Breast cancer;   

Others  :  1080440
DOI  :  10.1186/1471-2407-12-167

 received in 2012-03-15, accepted in 2012-05-04,  发布年份 2012

【 摘 要 】

Background

A life threatening illness such as breast cancer can lead to a secondary diagnosis of PTSD (post traumatic stress disorder) with intrusive thoughts and avoidance as major symptoms. In a former study by the research group, 80% of the patients with breast cancer reported a high level of stress symptoms close to the diagnosis, such as intrusive thoughts and avoidance behavior. These symptoms remained high throughout the study. The present paper presents the design of a randomized study evaluating the effectiveness and cost-effectiveness of a stress management intervention using a stepped-care design.

Method

Female patients over the age of 18, with a recent diagnosis of breast cancer and scheduled for adjuvant treatment in the form of chemotherapy, radiation therapy and/or hormonal therapy are eligible and will consecutively be included in the study. The study is a prospective longitudinal intervention study with a stepped-care approach, where patients will be randomised to one of two interventions in the final stage of treatment. The first step is a low intensity stress-management intervention that is given to all patients. Patients who do not respond to this level are thereafter given more intensive treatment at later steps in the program and will be randomized to more intensive stress-management intervention in a group setting or individually. The primary out-come is subjective distress (intrusion and avoidance) assessed by the Impact of Event Scale (IES). According to the power-analyses, 300 patients are planned to be included in the study and will be followed for one year. Other outcomes are anxiety, depression, quality of life, fatigue, stress in daily living and utilization of hospital services. This will be assessed with well-known psychometric tested questionnaires. Also, the cost-effectiveness of the intervention given in group or individually will be evaluated.

Discussion

This randomized clinical trial will provide additional empirical evidence regarding the effectiveness of a stress-management program given in group or individually during adjuvant therapy in terms of decreased stress, minimizing fatigue, and maintaining or enhancing patients’ quality of life and psychological well-being.

Trial registration

ClinicalTrials.gov Identifier: NCT01555645

【 授权许可】

   
2012 Nordin et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1 .

【 参考文献 】

• [1]Smith MY, Redd WH, Peyser C, et al.: Post-traumatic stress disorder in cancer: a review. Psychooncology 1999, 8:521-537.
• [2]Nordin K, Glimelius B: Predicting delayed anxiety and depression in patients with gastrointestinal cancer. Br J Cancer 1999, 79:525-529.
• [3]Korinek V, Barker N, Morin PJ, van Wichen D, de Weger R, Kinzler KW, Vogelstein B, Clevers H: Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC−/− colon carcinoma. Science 1997, 275(5307):1784-1787.
• [4]Groden J, Thliveris A, Samowitz W, Carlson M, Gelbert L, Albertsen H, Joslyn G, Stevens J, Spirio L, Robertson M, et al.: Identification and characterization of the familial adenomatous polyposis coli gene. Cell 1991, 66(3):589-600.
• [5]Lundberg U, Frankenhaeuser M: Stress and workload of men and women in high-ranking positions. J Occup Health Psychol 1999, 4(2):142-151.
• [6]Jacobsen P, Hann D: Cognitive-Behavioral Interventions. In Psycho-oncology. Edited by Breitbart W, Holland JC. Oxford University Press, New York; Oxford; 1998:1189.
• [7]Galceran J, Farinas I, Depew MJ, Clevers H, Grosschedl R: Wnt3a−/−−like phenotype and limb deficiency in Lef1(−/−)Tcf1(−/−) mice. Genes Dev 1999, 13(6):709-717.
• [8]Malanchi I, Peinado H, Kassen D, Hussenet T, Metzger D, Chambon P, Huber M, Hohl D, Cano A, Birchmeier W, et al.: Cutaneous cancer stem cell maintenance is dependent on beta-catenin signalling. Nature 2008, 452(7187):650-653.
• [9]Arving C, Sjoden PO, Bergh J, et al.: Individual psychosocial support for breast cancer patients: a randomized study of nurse versus psychologist interventions and standard care. Cancer Nurs 2007, 30(3):E10-E19.
• [10]Hellbom M, Brandberg Y, Kurland J, et al.: Assessment and treatment of psychosocial problems in cancer patients: an exploratory study of a course for nurses. Patient Educ Couns 2001, 45:101-106.
• [11]Arving C, Sjoden PO, Bergh J, et al.: Satisfaction, utilisation and perceived benefit of individual psychosocial support for breast cancer patients–a randomised study of nurse versus psychologist interventions. Patient Educ Couns 2006, 62:235-243.
• [12]Evans PC, Taylor ER, Coadwell J, Heyninck K, Beyaert R, Kilshaw PJ: Isolation and characterization of two novel A20-like proteins. Biochem J 2001, 357(Pt 3):617-623.
• [13]Bower P, Gilbody S: Stepped care in psychological therapies: access, effectiveness and efficiency. Narrative literature review. Br J Psychiatry 2005, 186:11-17.
• [14]Antoni MH, Wimberly SR, Lechner SC, et al.: Reduction of cancer-specific thought intrusions and anxiety symptoms with a stress management intervention among women undergoing treatment for breast cancer. Am J Psychiatry 2006, 163(10):1791-1797.
• [15]Horowitz M, Wilner N, Alvarez W: Impact of Event Scale: a measure of subjective stress. Psychosom Med 1979, 41:209-218.
• [16]Zigmond AS, Snaith RP: The hospital anxiety and depression scale. Acta Psychiatr Scand 1983, 67:361-370.
• [17]Aaronson NK, Ahmedzai S, Bergman B, et al.: The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993, 85:365-376.
• [18]Sprangers MA, Groenvold M, Arraras JI, et al.: The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field study. J Clin Oncol 1996, 14:2756-2768.
• [19]The EuroQol Group: EuroQol-a new facility for the measurement of health-related quality of life. Health Policy 1990, 16(3):199-208.
• [20]Smets EM, Garssen B, Bonke B, et al.: The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res 1995, 39(3):315-325.
• [21]Furst CJ, Ahsberg E: Dimensions of fatigue during radiotherapy. An application of the Multidimensional Fatigue Inventory. Support Care Cancer 2001, 9(5):355-360.
• [22]Jacobson MP, Friesner RA, Xiang ZX, Honig B: On the role of the crystal environment in determining protein side-chain conformations. J Mol Biol 2002, 320(3):597-608.
• [23]DE Åsenlöf P, Lindberg P: Behavioral goal assessment in patients with persistent musculoskeletal pain. Physiotherapy Theory and Practice 2004, 20:243-254.
• [24]Claesson M, Birgander LS, Jansson JH, et al.: Cognitive-behavioural stress management does not improve biological cardiovascular risk indicators in women with ischaemic heart disease: a randomized-controlled trial. J Intern Med 2006, 260(4):320-331.